nif:isString
|
-
This equilibrium allowed to obtain promising results from the clinical therapeutic application of IL-2 in the trial in patients with metastatic melanoma.28-30 Despite the development of new therapeutic approaches, high-dose IL-2 remains an important option for patients with melanoma and has an improved therapeutic window in the current era [31].
|